Predictive Value of Quantitative T2-Weighted MRI Morphometric Parameters for Clinically Significant Prostate Cancer in PI-RADS v2.1 ≥4 Lesions
This retrospective study demonstrates that among quantitative T2-weighted MRI morphometric parameters, lesion volume provides the highest diagnostic accuracy for distinguishing clinically significant prostate cancer from benign prostatic hyperplasia in PI-RADS v2.1 ≥4 lesions, with optimal cutoff values varying by anatomical zone.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of men, the path to understanding prostate health begins with a simple blood test that measures a protein called prostate-specific antigen. When this number rises, doctors often turn to a sophisticated form of magnetic resonance imaging, known as MRI, to look inside the prostate gland. This imaging system uses a standardized scoring method to rate suspicious spots found on the scan. A score of four or higher usually signals that a doctor should consider taking a tissue sample to check for cancer. However, this system is not perfect. It relies heavily on how a radiologist judges the size and shape of a lesion, often by measuring its longest line across a single slice of the image. Because prostate tumors can grow in irregular, three-dimensional shapes, a single line measurement might miss the true extent of the growth, leading to uncertainty about whether a spot is dangerous or harmless.
A team of researchers at the Fifth Affiliated Hospital of Anhui Medical University set out to see if looking at the full three-dimensional size of these spots could provide a clearer answer. They gathered data from 153 men who had undergone these MRI scans and subsequent biopsies. The researchers focused on 165 specific spots that had already been flagged as suspicious with a score of four or higher. For each spot, they did not just measure the longest line. Instead, they used the MRI images to calculate the total volume of the lesion, treating it as a complete, three-dimensional object. They compared these measurements against the final biopsy results to see which method better predicted the presence of clinically significant cancer, which is the type of disease that requires treatment.
The study revealed that the traditional method of measuring a single line across a tumor was less effective than measuring the entire volume. The researchers found that the spots containing significant cancer were consistently larger in every dimension than the benign spots, but the difference was most clear when looking at the total volume. In the outer part of the prostate, where most cancers start, the volume measurement had an AUC of 0.77 for identifying significant cancer while the AUC for ruling out benign spots was 0.85. In the inner part of the prostate, the volume measurement was even more accurate at spotting cancer, with an AUC over 0.82. The researchers determined that a specific volume threshold could help distinguish between dangerous and harmless spots: in the outer zone, a volume larger than 1.23 cubic centimeters suggested significant cancer, while in the inner zone, the threshold was 1.07 cubic centimeters.
These findings suggest that adding a calculation of total volume to the standard MRI review could help doctors make more confident decisions. Currently, the system relies on a score that can sometimes leave doctors guessing between a moderate risk and a high risk. By incorporating the total size of the lesion, the assessment becomes more precise. The researchers noted that this approach does not require new equipment, as the data is already present in the standard MRI images; it simply requires a different way of measuring what is already there. While the study was conducted at a single center and used biopsy results rather than full surgical removal of the prostate for confirmation, the results point toward a practical improvement. If these volume-based thresholds are confirmed in larger studies, they could become a standard part of the imaging report, helping to ensure that men with significant cancer receive timely care while sparing others from unnecessary procedures.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.